Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City
- PMID: 9114427
- PMCID: PMC232749
- DOI: 10.1128/jcm.35.5.1281-1283.1997
Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City
Abstract
A commercial line probe assay kit (Inno-LiPA Rif.TB) for rapid identification of mutations in the rpoB gene associated with rifampin resistance in Mycobacterium tuberculosis was evaluated with a collection of 51 rifampin-resistant strains. Nine distinct rpoB mutations were identified. Concordances with automated sequence results for five wild-type kit probes and four probes for specific mutations were 94.1 and 100%, respectively. Overall concordance of the line probe assay kit with phenotypic rifampin susceptibility testing results was 90.2%.
Comment in
-
Re: Ethical studies, ethical publication.Occup Med (Lond). 2009 Jun;59(4):281. doi: 10.1093/occmed/kqp047. Occup Med (Lond). 2009. PMID: 19471041 No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
